Search
for
Sort by
Research 91–120 of 103
- Effectiveness and Safety Profile of Cisplatin Versus Nab-Paclitaxel Concomitant Chemoradiotherapy in Postoperative Early-Stage Cancer of Cervix
- Inflammatory Signatures and Biological Markers in Platelet-Rich Plasma Therapy for Hair Regrowth: A Comprehensive Narrative Analysis
- Confirmation of Metformin-Induced Acute Generalized Exanthematous Pustulosis Through a Positive Dechallenge-Rechallenge Test: A Case Report and Review of Cutaneous Manifestations Associated With Metformin
- Selected abstracts from the 47th meeting of the Irish Endocrine Society Sligo, 24th & 25th November 2023
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Recent progress of polymeric microneedle-assisted long-acting transdermal drug delivery
- Re-Densification Effect of Pressure-Injected Peptide-Hyaluronic Acid Combination on Male Androgenic Alopecia
- Dissecting the genetic variations associated with response to first-line chemotherapy in patients with small cell lung cancer: a retrospective cohort study
- E-Poster
- Gastric cancer; actualities and perspectives of early diagnosis and targeted therapy
- Targeted immunotherapy for hair regrowth and regeneration
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- Nivolumab-Induced Alopecia Areata: A Case Report and Literature Review
- Resolution of paraneoplastic alopecia areata following nivolumab in a patient with metastatic melanoma
- A case of bullous pemphigoid in a malignant melanoma patient following an increased Th2/Th1 ratio in peripheral blood cells after nivolumab treatment
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- Eosinophilic folliculitis of the scalp associated with PD‐1/PDL1 inhibitors
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine
- Cemiplimab-Induced Alopecia Areata
- ODP342 Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy
- A bibliometric study of the top 100 most cited articles on melanoma: insights into research trends and characteristics
- 15460 Perifollicular pink halo: A potential dermoscopic marker of inflammation in central centrifugal cicatricial alopecia
- Biological therapy in the treatment of melanoma
- BH14 Multiple sclerosis and alopecia areata: drug-induced alopecia areata or coexisting autoimmune phenomena?
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors